QOL-2C: AYUSH Drug developed by CCRAS for cancer patients
The Central Council for Research in Ayurvedic Sciences (CCRAS) has undertaken development of coded drug AYUSH QOL-2C for improving quality of life in cancer patients. It had conducted clinical studies of the drug in breast cancer patients at St. John’s Medical College, Bengaluru and AIIMS, New Delhi and in lung cancer patients at Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur.
Central Council for Research in Ayurvedic Sciences (CCRAS)
CCRAS is autonomous body under the Ministry of AYUSH. It is apex body in India for formulation, coordination, development and promotion of research on scientific lines in Ayurveda and Sowa-Rigpa system of medicine. It undertakes scientific activities through its 30 Institutes/Centres/Units located all over the country and also through collaborative studies with various Universities, Hospitals and Institutes. It is headquartered in New Delhi.
Related Posts
Month: Current Affairs - March, 2018
Dr.Anand Kar
March 15, 2018 at 1:36 pmHope, with the newly developed drug by CCRAS, breast cancer will be eradicated from India & abroad. However, long term safety evaluation is a must, if not done so far.
A.Kar